Healthcare

John Paulson, former hedge-fund manager, bought large blocks of Bausch Health and Perpetua Resources through funds.

Five years ago, scientists and investors were excited about gene therapy offering one-and-done cures for deadly diseases. Today, much of the enthusiasm has dried up.

The Merck rival faces intense competition that could limit multiple expansion, Stifel analysts say.

The combined retirement and disability fund is projected to run dry in 2034, one year earlier than reported last year, according to the annual Social Security and Medicare Trustees report.

Solar stocks drop sharply as Senate Republicans detail changes to Trump’s tax-and-spending bill that would phase out solar, wind and energy tax credits by 2028.

The deal is worth an initial $561 million, with potential for $234 million in add-ons.

The health secretary fired all the members of the Advisory Committee on Immunization Practices late on Monday.

There are two weeks to go until the panel’s next scheduled meeting. As of Wednesday morning, the committee has no known members.

The head of the Department of Health and Human Services fired all the members of a committee advising the CDC on vaccine policy.

Apple’s artificial intelligence projects, L.A. protesters target Waymo driverless cars, RFK Jr. fires vaccine advisory board, and more news to start your day.

He said the Department of Health and Human Services is “putting the restoration of public trust above any pro- or antivaccine agenda,” in an op-ed in The Wall Street Journal.

The selloff, based on the faintest whisps of news about the fate of the budget negotiations, shows just how anxious the bill has left investors.

Deutsche Bank is the first group on Wall Street to issue a Sell rating on shares of Intuitive Surgical.

At least 79 people—many from California, Nevada, and Washington—have gotten ill.

Stocks that aren’t sensitive to economic ups and downs are a smart way to protect your portfolio.

In an area where demand for workers is outstripping the supply, hiring is slowing.

The index is having trouble staying above the 6000 level, indicating that not enough has changed in the economic environment to stoke confidence that stocks could soar from here.

Vera Therapeutics stock rocketed nearly 70% on Monday on upbeat data for a kidney-disease trial. Shares are tumbling Friday on a rival’s study.

U.S. drug companies are increasingly licensing experimental medicines invented by Chinese firms. The recent deals could be worth up to $25 billion.

Some Republican lawmakers have joined Democrats in opposing cuts to Medicaid.

He initially announced the move last Friday while visiting a U.S. Steel factory in Pennsylvania.

Hims agreed to buy private European telehealth firm Zava, which operates in the U.K., Germany, France, and Ireland.

The dollar’s worst start to a year on record, Bristol Myers plans to develop new cancer drug, Apple’s WWDC is coming, and more news to start your day.

The deal announced Monday is Sanofi's third of the year so far.

Moderna said mNEXSPIKE was approved by the FDA for use in adults aged 65 and up, as well as some individuals aged 12 to 64.